194 related articles for article (PubMed ID: 36652145)
1. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
[TBL] [Abstract][Full Text] [Related]
2. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
3. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
[TBL] [Abstract][Full Text] [Related]
4. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
[TBL] [Abstract][Full Text] [Related]
5. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
6. Comparative Transcriptomic Analysis of Cerebral Organoids and Cortical Neuron Cultures Derived from Human Induced Pluripotent Stem Cells.
Kathuria A; Lopez-Lengowski K; Watmuff B; Karmacharya R
Stem Cells Dev; 2020 Nov; 29(21):1370-1381. PubMed ID: 32862797
[TBL] [Abstract][Full Text] [Related]
7. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
[TBL] [Abstract][Full Text] [Related]
8. Down Syndrome iPSC-Derived Astrocytes Impair Neuronal Synaptogenesis and the mTOR Pathway In Vitro.
Araujo BHS; Kaid C; De Souza JS; Gomes da Silva S; Goulart E; Caires LCJ; Musso CM; Torres LB; Ferrasa A; Herai R; Zatz M; Okamoto OK; Cavalheiro EA
Mol Neurobiol; 2018 Jul; 55(7):5962-5975. PubMed ID: 29128905
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
[TBL] [Abstract][Full Text] [Related]
10. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
Bansal P; Banda EC; Glatt-Deeley HR; Stoddard CE; Linsley JW; Arora N; Deleschaux C; Ahern DT; Kondaveeti Y; Massey RE; Nicouleau M; Wang S; Sabariego-Navarro M; Dierssen M; Finkbeiner S; Pinter SF
Sci Adv; 2024 Jun; 10(23):eadj0385. PubMed ID: 38848354
[TBL] [Abstract][Full Text] [Related]
11. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
[TBL] [Abstract][Full Text] [Related]
12. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
[TBL] [Abstract][Full Text] [Related]
13. Modeling amyloid beta and tau pathology in human cerebral organoids.
Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
[TBL] [Abstract][Full Text] [Related]
14. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
[TBL] [Abstract][Full Text] [Related]
15. Cerebral organoids model human brain development and microcephaly.
Lancaster MA; Renner M; Martin CA; Wenzel D; Bicknell LS; Hurles ME; Homfray T; Penninger JM; Jackson AP; Knoblich JA
Nature; 2013 Sep; 501(7467):373-9. PubMed ID: 23995685
[TBL] [Abstract][Full Text] [Related]
16. Asynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome.
Li Z; Klein JA; Rampam S; Kurzion R; Campbell NB; Patel Y; Haydar TF; Zeldich E
Front Neurosci; 2022; 16():932384. PubMed ID: 36161168
[TBL] [Abstract][Full Text] [Related]
17. Standards for Deriving Nonhuman Primate-Induced Pluripotent Stem Cells, Neural Stem Cells and Dopaminergic Lineage.
Yang G; Hong H; Torres A; Malloy KE; Choudhury GR; Kim J; Daadi MM
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227600
[TBL] [Abstract][Full Text] [Related]
18. Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics.
Handel AE; Chintawar S; Lalic T; Whiteley E; Vowles J; Giustacchini A; Argoud K; Sopp P; Nakanishi M; Bowden R; Cowley S; Newey S; Akerman C; Ponting CP; Cader MZ
Hum Mol Genet; 2016 Mar; 25(5):989-1000. PubMed ID: 26740550
[TBL] [Abstract][Full Text] [Related]
19. Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.
Ponroy Bally B; Farmer WT; Jones EV; Jessa S; Kacerovsky JB; Mayran A; Peng H; Lefebvre JL; Drouin J; Hayer A; Ernst C; Murai KK
Hum Mol Genet; 2020 Mar; 29(5):785-802. PubMed ID: 31943018
[TBL] [Abstract][Full Text] [Related]
20. Restoration of keratinocytic phenotypes in autonomous trisomy-rescued cells.
Tanuma-Takahashi A; Inoue M; Kajiwara K; Takagi R; Yamaguchi A; Samura O; Akutsu H; Sago H; Kiyono T; Okamoto A; Umezawa A
Stem Cell Res Ther; 2021 Aug; 12(1):476. PubMed ID: 34433490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
